HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia. Arza-Apalategi S, Heuts BMH, Bergevoet SM, Meering R, et al. Leukemia 2024 Dec 4. doi: 10.1038/s41375-024-02485.

Read + Share

Amedeo Smart

Independent Medical Education

Arza-Apalategi S, Heuts BMH, Bergevoet SM, Meering R, et al. HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia. Leukemia 2024 Dec 4. doi: 10.1038/s41375-024-02485.
PMID: 39633068